Showing results (1-10 of 2,939) with videos related to
Sort By:
Pageof 294
Molecular Pharmaceutics|October 13, 2011
Effects of solution concentration on the physicochemical properties of a polymeric anticancer therapeuticLili X Peng, Lei Yu, Stephen B Howell, et al.Journal of Chemical Information and Modeling|October 15, 2011
Aggregation properties of a polymeric anticancer therapeutic: a coarse-grained modeling studyLili X Peng, Lei Yu, Stephen B Howell, et al.Journal of Molecular Modeling|March 2, 2011
Coarse-grained modeling study of nonpeptide RGD ligand density and PEG molecular weight on the conformation of poly(γ-glutamyl-glutamate) paclitaxel conjugatesLili X Peng, Sanjib K Das, Lei Yu, et al.Biopolymers|June 22, 2010
Characterization of a clinical polymer-drug conjugate using multiscale modelingLili X Peng, Anthony Ivetac, Akshay S Chaudhari, et al.Cancer Chemotherapy and Pharmacology|August 18, 2009
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs AbraxaneZhongling Feng, Gang Zhao, Lei Yu, et al.Cancer Chemotherapy and Pharmacology|July 14, 2009
Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenograftsXinghe Wang, Gang Zhao, Sang Van, et al.Molecular Cancer Therapeutics|May 30, 2006
DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistanceXinjian Lin, Stephen B HowellMetal-Based Drugs|January 29, 2011
Regulation of Cisplatin cytotoxicity by cu influx transportersPaolo Abada, Stephen B HowellCritical Reviews in Oncology/Hematology|December 21, 2004
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugsRoohangiz Safaei, Stephen B HowellCancer Chemotherapy and Pharmacology|September 20, 2005
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transportersGoli Samimi, Stephen B HowellPageof 294